Underpowered and too many different snake species
Agreement I do not Agree Body I have followed the development of varespladib for several years. It remains a promising drug with superb animal data. This ambitious study bit of more than it can chew…
Read the full articleYou might also wanna read
Clarification of sex-related differences in DKA at T1D diagnosis
BMJ Global Health·8d ago
The IGISPA Protocol: Methodological Circularity and the Institutionalization of Low-Quality Evidence
BMJ Global Health·9d ago
Persistent Gaps in LDL-C Goal Attainment Among High-Risk Patients With Diabetes
BMJ Global Health·11d ago
Post-traumatic BPPV after head injury: from missed diagnosis to treatable target
BMJ Global Health·14d ago
Are rising costs a marker of increasing need, or of delayed access to appropriate care?
BMJ Global Health·17d ago
Response to correspondence by Tomoyuki Kawada
BMJ Global Health·18d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.